Etibo 250mg

Lapatinib is a targeted therapy medication primarily used in the treatment of HER2-positive breast cancer, particularly in cases where other treatments have not been effective. It belongs to a class of drugs called tyrosine kinase inhibitors (TKIs), which work by blocking specific proteins (such as HER2 and EGFR) that promote cancer growth and spread. By inhibiting these proteins, lapatinib helps to slow down or stop the growth of cancer cells, thereby reducing tumor size and potentially improving patient outcomes.

In addition to breast cancer, lapatinib may also be used in combination with other medications to treat certain types of advanced or metastatic HER2-positive stomach cancer. It is typically administered orally in the form of tablets or capsules, allowing for convenient dosing and administration. Like all medications, lapatinib may cause side effects, which can vary from person to person and may include diarrhea, rash, fatigue, and potential cardiac effects. Close monitoring by healthcare professionals is essential to manage any adverse reactions and ensure the medication’s effectiveness.